Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 6,208 shares at $77.09 ($479K) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Scheduled sale ($479k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.09 | 3,104 | $239K | 50.0% |
| 2 | $77.09 | 3,104 | $239K | 50.0% |
| Total | $77.09 avg | 6,208 | $479K | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $425K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |